*** Disclaimer: This blog post represents some shameless self-promotion. ***
I am delighted to announce that our most recent work, DeLinker, was recently published in the Journal of Chemical Information and Modeling (link).
Our collaborator, Prof. Geoff Hutchison from the University of Pittsburg recently took part in the Royal Society of Chemistry’s 2020 Twitter Poster Conference, to highlight the great work carried out by one of my DPhil students, Lucian Leung Chan, on the application of Bayesian optimization to conformer generation:
The reception of ML approaches for the drug discovery pipeline, especially when focused on the hit to lead optimization process, has been rather skeptical by the medchem community. One of the main drivers for that is the way many ML publications benchmark their models: Historic datasets are split into two parts, with the larger part used to train and the smaller to test ML models. In order to standardize that validation process, computational chemists have constructed widely used benchmark datasets such as the DUD-E set, which is commonly used as a standard for protein-ligand binding classification tasks. Common criticism from medicinal chemists centers on the main problem associated with benchmark datasets: the absence of direct lab validation.
Continue readingA recently just-released publication from Ngyuen et al. ing JCIM pointed out that while AutoDock Vina is faster, AutoDock 4 tends to have better correlation with experimental binding affinity.1
[This post has been edited to provide more information about the cited paper, as well as providing additional citations.]
Ngyuyen et al. selected 800 protein-ligand complexes for 47 protein targets that had both experimental PDB structures complexed with a ligand, as well as their associated binding affinity values.
Continue readingThis is an interesting paper by Zhavoronkov, et al. that recently got published in Nature Biotechnology as a brief communication: https://www.nature.com/articles/s41587-019-0224-x. The paper describes a new deep generative model called generative tensorial reinforcement learning (GENTRL), which enables optimization for synthetic feasibility, novelty, and biological activity. In this work, authors have deigned, synthesized, and experimentally validated molecules targeting discoidin domain receptor 1 (DDR1) in less than two months. The code for GENTRL is available here: https://github.com/insilicomedicine/gentrl.
Reference: Zhavoronkov, A. et al. Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nature Biotechnology 2019, 37, 1038-1040.
“Hotspot” is one of those extremely versatile words, similar to “model” and “buffer”, which can mean a variety of things depending on context. According to Merriam-Webster, a hotspot is “a place of more than usual interest, activity, or popularity”. This is the most general definition of the concept I could find in a quick search, and the one I find closest in spirit to the way hotspots are perceived in a structural biology context. What this blog post is definitely not about are hotspots as “areas of political, military, or civil unrest” (my experience with them has so far been mostly peaceful), or anything to do with geology, WiFi connections, or forest fires.
However, even within the context of structural biology and structure-based drug design, the word “hotspot” has multiple meanings. In this blog post, I will try to summarise the main ones I have come across, the (sometimes subtle) differences between them, and provide a few useful papers to serve as an entry point for interested readers. Continue reading
NeurIPS is the largest machine learning conference (by number of participants), with over 8,000 in 2017. This year, the conference will be held in Vancouver, Canada from 8th-14th December.
Recently, the list of accepted papers was announced, with 1430 papers accepted. Here, I will highlight several of potential interest to the chem-/bio-informatics communities. Given the large number of papers, these were selected either by “accident” (i.e. I stumbled across them in one way or another) or through a basic search (e.g. Ctrl+f “molecule”).
Continue readingFresh off the pages of Therapeutic Advances in Endocrinology and Metabolism comes a warning no self-respecting sweet tooth should ignore.
“Liquorice is not just a candy,” write a team of ten from Chicago. “Life-threatening complications can occur with excess use.” Hold on to your teabags. Liquorice – the Marmite of sweets – is about to become a lot more sinister.
Continue readingHi everyone,
My blogpost this time around is a list of conferences popular with OPIGlets. You are highly likely to see at least one of us attending or presenting at these meetings! I’ve tried to make it as exhaustive as possible (with thanks to Fergus Imrie!), listing conferences in upcoming chronological order.
(Most descriptions are slightly modified snippets taken from the official websites.)
Crystallographic fragment based lead discovery is a now a routine technique, which can sample 1000’s of compounds per week. But how do we identify the most appropriate compounds to screen against our target of interest?
Continue reading